Argobio

In March 2021, Angelini Pharma announced its participation in Argobio, an incubator of European start-ups dedicated to life sciences and early-stage projects from prominent European academic research.

Its focus will be on selected therapeutic areas, rare diseases, neurological disorders, oncology and immunology, endeavoring to develop promising technology platforms for therapeutic products.